Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Update on contraception].

O Graesslin1, C Quereux

  • 1Institut Mère-Enfant Alix-de-Champagne, Centre Hospitalier Universitaire, 45, rue Cognacq-Jay, 51092 Reims Cedex. ograesslin@chu-reims.fr

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|October 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic literature review and meta-analysis of postoperative complications of surgical management of vulvar cancer: what is the impact of frailty factors?

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Impact of age on surgical excision margins for vulvar squamous cell carcinomas: A multicenter study by the francogyn group.

Surgical oncology·2024
Same author

Impact of age on tumor size in vulvar cancer: A multicenter study by the Francogyn group.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2024
Same author

Management of women with abnormal uterine bleeding: Clinical practice guidelines of the French National College of Gynaecologists and Obstetricians (CNGOF).

European journal of obstetrics, gynecology, and reproductive biology·2023
Same author

Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.

Maturitas·2022
Same author

Evaluation of obstetric management of women with macrosomic foetuses in two Level 3 maternity hospitals in France and identification of predictive factors for obstetric and neonatal complications.

European journal of obstetrics, gynecology, and reproductive biology·2022
Same journal

[Neuroprotection for preterm infants with antenatal magnesium sulphate].

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Is universal screening for cervical length among singleton pregnancies with no history of preterm birth justified?]

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Lifestyle recommendations for prevention of spontaneous preterm birth in asymptomatic pregnant women].

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Guidelines for clinical practice: Prevention of spontaneous preterm birth (excluding preterm premature rupture of membranes) - Introduction].

Journal de gynecologie, obstetrique et biologie de la reproduction·2017
Same journal

[Psychological aspects of abortion].

Journal de gynecologie, obstetrique et biologie de la reproduction·2016
Same journal

[Induced abortion: Guidelines for clinical practice - Introduction].

Journal de gynecologie, obstetrique et biologie de la reproduction·2016
See all related articles

Advances in hormonal contraception offer women safe and effective options beyond oral pills. New delivery systems improve efficacy and tolerability, reducing unintended pregnancies.

Area of Science:

  • Reproductive Health
  • Endocrinology

Context:

  • Hormonal contraceptives have evolved significantly since the 1960s.
  • Oral contraception risks and benefits are better understood.
  • New hormone delivery systems aim to improve user experience and outcomes.

Purpose:

  • To review recent advances in contraceptive technology.
  • To highlight novel hormone delivery systems for pregnancy prevention.
  • To assess the efficacy and tolerability of new contraceptive methods.

Summary:

  • New contraceptive options include hormone-containing intra-uterine systems, transdermal patches, vaginal rings, subdermal implants, and injectables.
  • These methods offer high efficacy and improved ease of use compared to daily oral pills.
  • Hysteroscopic tubal sterilization is also presented as a highly effective procedure.

Related Experiment Videos

Impact:

  • Improved contraceptive options can lead to better user acceptance and compliance.
  • Enhanced methods have the potential to reduce rates of unintended pregnancies and elective abortions.
  • Advances provide users with more choices, offering better efficacy and tolerability.